Adjuvant intravesical therapy in intermediate‐risk non‐muscle‐invasive bladder cancer.

MLA

Laukhtina, Ekaterina, et al. “Adjuvant Intravesical Therapy in Intermediate‐risk Non‐muscle‐invasive Bladder Cancer.” BJU International, vol. 134, no. 4, Oct. 2024, pp. 644–51. EBSCOhost, https://doi.org/10.1111/bju.16371.

APA

Laukhtina, E., Gontero, P., Babjuk, M., Moschini, M., Teoh, J. Y., Rouprêt, M., Trinh, Q., Chlosta, P., Nyirády, P., Abufaraj, M., Soria, F., Klemm, J., Bekku, K., Matsukawa, A., & Shariat, S. F. (2024). Adjuvant intravesical therapy in intermediate‐risk non‐muscle‐invasive bladder cancer. BJU International, 134(4), 644–651. https://doi.org/10.1111/bju.16371

Chicago

Laukhtina, Ekaterina, Paolo Gontero, Marko Babjuk, Marco Moschini, Jeremy Yuen‐Chun Teoh, Morgan Rouprêt, Quoc‐Dien Trinh, et al. 2024. “Adjuvant Intravesical Therapy in Intermediate‐risk Non‐muscle‐invasive Bladder Cancer.” BJU International 134 (4): 644–51. doi:10.1111/bju.16371.